Table 2.

IgG-associated glycans detected in this study. Additionally included are the p-values and area-under-the-curve (AUC) scores for the comparisons of the control samples to the baseline ovarian cancer samples and for the baseline ovarian cancer samples to the post-experimental treatment samples.

	m/z	AVG REL INT (Control)	AVG REL INT (Ovarian Cancer)	AVG REL INT (End-stage)	p-value (Control v. Ovarian cancer)	p-value (Ovarian cancer v. End-stage)	AUC (Control vs. Ovarian cancer)	AUC (Ovarian cancer vs. End-stage)
	1595.822	1.91	2.67	2.4	0.161	0.717
	1677.875	0.892	1.03	1.14	0.486	0.762
	1799.932	1.96	2.36	2.26	0.376	0.861
	1810.946	0.155	0.243	0.243	2.92E-03	0.163	0.81	0.349
	1840.952	0.524	0.752	0.579	0.015	0.129	0.737	0.311
	1851.955	28.7	36.2	32.2	5.35E-03	0.184	0.753	0.345
	1881.97	1.57	1.24	1.55	0.166	0.534
	1922.996	0.434	0.702	0.723	3.47E-03	0.865	0.774	0.512
	2004.033	0.441	0.563	0.539	0.343	0.887
	2056.057	30.0	25.4	26	7.13E-05	0.608	0.142	0.541
	2086.062	0.955	0.712	0.84	0.031	0.513	0.316	0.44
	2097.075	4.5	5.51	4.85	0.056	0.379
	2127.09	0.521	0.524	0.56	0.949	0.614
	2208.121	0.525	0.622	0.601	0.544	0.918
	2260.157	10.6	6.81	7.8	3.62E-04	0.301	0.179	0.641
	2301.176	5.23	4.06	4.19	8.47E-03	0.769	0.252	0.454
	2331.192	0.134	0.097	0.1	0.018	0.831	0.297	0.541
	2412.217	0.0516	0.0995	0.112	0.037	0.673	0.687	0.622
	2417.233	0.703	0.514	0.647	5.07E-03	0.115	0.213	0.698
	2447.242	1.15	1.29	1.63	0.476	0.197
	2505.279	0.849	0.543	0.573	0.013	0.772	0.282	0.646
	2621.326	3.54	2.72	3.33	0.046	0.195	0.324	0.641
	2692.36	0.208	0.183	0.197	0.598	0.790
	2808.409	1.41	2.1	3.51	0.021	0.004	0.671	0.789
	2866.441	1.69	1.04	1.03	0.618	0.978
	2982.491	0.424	0.449	0.581	0.758	0.251
	3227.612	0.249	0.235	0.274	0.798	0.534